IL5 and chronic obstructive pulmonary disease: Importantly, although not all of the METREX, METREO, GALATHEA, and TERRANOVA studies show statistically significant results, these studies provide insights into the effects of anti-IL-5 treatment in both eosinophilic and non-eosinophilic COPD [88, 90].